Fertility experts urge UK to adopt new DNA screening for IVF embryos
By Nicola Davis,
The Guardian
| 07. 04. 2016
A new technique to genetically screen IVF embryos should be considered for use in the UK, fertility experts say. The call comes after research revealed it could help doctors select embryos that have the best of chance of leading to a pregnancy.
Pre-implantation genetic screening (PGS) is more common in the US than the UK, and is used by doctors to flag up embryos with an abnormal number of chromosomes - the main reason why embryos fail to implant in the womb.
But other factors also affect whether an embryo will implant: around a third of embryos with the correct number of chromosomes also fail to lead to a pregnancy when transferred to the womb.
Intriguingly, scientists have recently found that many of these apparently healthy embryos have something in common: they have increased levels of the DNA that is found within mitochondria - the tiny energy-generating structures that sit inside cells. The discovery, scientists say, offers a new tool for genetically screening embryos with the technique, known as mitochondrial DNA quantification, recently made available in the US.
Now fertility...
Related Articles
By Staff, National Women's Law Center | 08.13.2025
INTRODUCTION
Baby bonuses. Motherhood medals. Fertility tracking. You may have heard of these policy proposals as solutions from the Trump administration to help encourage women to have more children.
Besides falling short of ensuring that people have what they need...
By Zusha Elinson, The Wall Street Journal | 08.12.2025
BERKELEY, Calif.—Tsvi Benson-Tilsen, a mathematician, spent seven years researching how to keep an advanced form of artificial intelligence from destroying humanity before he concluded that stopping it wasn’t possible—at least anytime soon.
Now, he’s turned his considerable brainpower to promoting...
By Cade Metz, The New York Times | 08.04.2025
Image by Mike MacKenzie / CC BY 2.0
In downtown Berkeley, an old hotel has become a temple to the pursuit of artificial intelligence and the future of humanity. Its name is Lighthaven.
Covering much of a city block, this...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...